Global business with 31 manufacturing plants and 7 R&D centres
Europe
We manufacture injectable medicines in Europe, supplying products to the US, the MENA, and Europe. We have high-quality manufacturing plants in Germany, Italy and Portugal.
Middle East and North Africa (MENA)
The region’s principal player, we create branded generic medicines and are a leading licensing partner. In MENA, we are one of the largest pharmaceutical companies and a ‘partner of choice’.
US
We are the third largest generic injectable manufacturer and a top ten generic company overall in the US. We have a strong presence in the non-injectables market.
Rest of the World
We have a small presence beyond our core geographies.